204
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Aromas from Quebec. VI. Morella pensylvanica from the Magdalen Islands: a (-)-α-bisabolol-rich oil featuring a new bisabolane ether

ORCID Icon, , , , &
Pages 319-329 | Received 07 Sep 2017, Accepted 22 Apr 2018, Published online: 15 May 2018
 

Abstract

Aerial parts of northern bayberry (Morella pensylvanica (Mirbel) Kartesz) from the Magdalen Islands were submitted to steam distillation to evaluate both yield and composition of essential oil and hydrosol. It yielded 0.15% (m/m) of a pleasantly scented essential oil featuring a different composition than that reported in Connecticut. This oil appeared to be rich in (-)-α-bisabolol, β-caryophyllene, linalyl acetate, geraniol and γ-terpinene. It also contained a new α-bisabolol derivative that was identified as 2,2,6-trimethyl-6-(4-methylcyclohex-3-en-1-yl)tetrahydro-2H-pyran, and named Magdalen ether. The hydrosol contained 160 mg/L of aromatic compounds among which α-bisabolol, linalool, α-terpineol and α-bisabolol oxide B, and a few minor phenolic compounds. The oil was tested for its cytotoxicity in vitro on WS-1 human fibroblasts and was shown to be four times less cytotoxic than the generally recognized as safe α-bisabolol, but did not show anti-inflammatory properties through inhibition of nitrous oxide production by murine macrophages.

Acknowledgements

We thank Groupe BoreaRessources for pilot scale distillation and Yves Leblanc for the plant harvest and delivery to the distillation site.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.